Navigation Links
Growth Fuels Expansion As PendoTECH Relocates New Jersey Headquarters
Date:3/19/2013

PRINCETON, N.J., March 19, 2013 /PRNewswire-iReach/ -- PendoTECH, a company dedicated to designing products to optimize the bioprocess, announced today that it has relocated its regional headquarters to an expanded facility in Princeton, NJ.  The office space will serve as the company's local base of operation now that it has moved out of its former facility of 5 years.

"We are pleased to announce our relocation within the Princeton, NJ area; home to some of the biggest pharmaceutical companies in the country and in the heart of the state designated industry cluster known as Einstein's Alley (www.einsteinsalley.org )," shares PendoTECH's James Furey .  "The new office includes upgraded amenities such as client meeting rooms, expanded reception area, product showroom, a state-of-the-art laboratory and space for future growth.  The move will enable greater access to our current and emerging clients."

A pioneer in the area of in-line, low cost sensory technology, PendoTECH is one of the most recognized brands known for enhancing the production process for biopharmaceuticals such as antibodies, recombinant proteins, vaccines, gene therapy and cell therapy products.   The need for a larger office became more pressing due to a steady increase in product demands. 

About PendoTECH
PendoTECH is committed to providing value-added products and services to companies in the biopharmaceutical industry for enhanced development and production of products derived mainly from biological systems.   Products include Single Use Pressure Sensors, PressureMAT- a monitor, alarm, and transmitter system designed for use with the pressure sensors, and our integrated Process Control Systems for applications such as TFF/Crossflow Filtration, Filter Screening, Virus-Depth Filtration, Bioreactor Pressure Control/Monitoring and more. 

As the number of biologicals produced by cell culture increases and the industry matures, new technologies and process approaches are available for comparison to the existing ones for evaluation of enhanced production output and reduced cost of goods.  Contact us at http://www.pendotech.com/ or 609-799-2299 for more information. 



Media Contact: Jim Furey PendoTECH, 609-799-2299, tashieka@pendotech.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE PendoTECH
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Shire Delivers Strong First Quarter Performance and Reiterates its Expectation of Good Full Year Earnings Growth
2. Endocrinology Market to 2018 - Advanced Injection Devices for Growth Hormone and Somatostatin will Improve Ease of Use for Patients
3. Amgen to Present at the Baird Growth Stock Conference
4. Veeva Systems Announces Dramatic Growth in Europe
5. Aethlon Medical to Present at Todays Security Research Associates 8th Annual Growth Conference
6. Contract Research Organizations Set to Experience Rapid Growth as Development Costs for New Drugs Continue to Rise
7. Millennium Surgical Corp. Announces Sales Figures, Growth
8. MicroRNA Research to Trigger Tremendous Growth in Related Tools Market, Says Frost & Sullivan
9. Masimo to Present at William Blair & Company 32nd Annual Growth Stock Conference
10. VitaTech Adds New Capacity for Production and Customer Interface, Attributes Growth to Strategic Customer Partnerships
11. Perrigo Company To Present At The William Blair Growth Stock Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... DUBLIN , Dec 1, 2016 ... report "Drug Delivery in Cancer - Technologies, Markets and Companies" ... , ... a challenge in management of cancer The market value ... separate. Cancer market estimates from 2015-2025 are given according to organs ...
(Date:12/2/2016)... , Dec. 1, 2016 Around the ... country, region and each habitable land present over earth. ... every individual once in a life time this is ... care available until now. Given the steady increase in ... together with the spiraling healthcare costs of treatment, there ...
(Date:12/2/2016)... Allergan plc (NYSE: AGN ), a ... previously announced Accelerated Share Repurchase (ASR) Program. Logo - ... ... previously announced, the Company entered into a variable tenor ASR ... repurchase $10 billion of its ordinary shares. Approximately 40.5 million ...
Breaking Medicine Technology:
(Date:12/2/2016)... York, NY (PRWEB) , ... December 02, 2016 ... ... featuring an inspirational interview of two ostomy patients, standing as living proof that ... people suffer from digestive diseases and issues that spike around the holidays. This ...
(Date:12/2/2016)... (PRWEB) , ... December 02, 2016 , ... ... edition of "Cardiovascular Health" in USA Today, which covers the innovative treatments, therapeutic ... health while maintaining fulfilling lives. “We are prolonging life 6 years in the ...
(Date:12/2/2016)... ... December 02, 2016 , ... ... diagnostic imaging systems and the first company to offer robotic imaging to ... at their tradeshow booth # 941 for the American Association of Equine Practitioners ...
(Date:12/2/2016)... ... 2016 , ... Yisrayl Hawkins, at The House of Yahweh in Abilene, Texas, ... Bible Prophecy. Yisrayl says this generation, known as the Last Generation, started in 1934 ... details line up exactly with Bible Prophecy – a protected way for those who ...
(Date:12/2/2016)... ... December 02, 2016 , ... ... needy individuals and families from eight different sites throughout Miami-Dade and Broward counties. ... 1,000 volunteers worked very hard on Thanksgiving morning by putting together individual meals ...
Breaking Medicine News(10 mins):